ADMS - Adamas to Present at Upcoming September Investor Conferences
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that management will present at the following virtual investor conferences during the month of September 2021:
- H.C. Wainwright 23rd Annual Global Investment Conference, a pre-recorded presentation will be available beginning on Monday, September 13 at 7:00 am ET (4:00 am PT)
- Cantor Fitzgerald Global Healthcare Conference, on Wednesday, September 29 at 4:40 pm ET (1:40 pm PT)
Replays of both events will be available on the investor relations section of the Adamas website at http://ir.adamaspharma.com/events-presentations . The replays will remain available for approximately 30 days from their original posting.
About Adamas Pharmaceuticals, Inc.
At Adamas our vision is clear – to deliver innovative medicines that reduce the burden of neurological diseases on patients, caregivers and, society. We are a fully-integrated company focused on growing a portfolio of therapies to address a range of neurological diseases. For more information, please visit www.adamaspharma.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210830005541/en/
Media:
Sarah Mathieson
Vice President, Corporate Communications
510-450-3528
smathieson@adamaspharma.com
Investors:
Peter Vozzo
Managing Director
Westwicke/ICR
443-213-0505
peter.vozzo@westwicke.com